文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

FET 融合致癌蛋白与肉瘤中的 BRD4 和 SWI/SNF 染色质重塑复合物亚型相互作用。

FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.

机构信息

Department of Laboratory Medicine, Sahlgrenska Academy, Sahlgrenska Center for Cancer Research, Institute of Biomedicine, University of Gothenburg, Sweden.

Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden.

出版信息

Mol Oncol. 2022 Jul;16(13):2470-2495. doi: 10.1002/1878-0261.13195. Epub 2022 Mar 19.

DOI:10.1002/1878-0261.13195
PMID:35182012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9251840/
Abstract

FET fusion oncoproteins containing one of the FET (FUS, EWSR1, TAF15) family proteins juxtaposed to alternative transcription-factor partners are characteristic of more than 20 types of sarcoma and leukaemia. FET oncoproteins bind to the SWI/SNF chromatin remodelling complex, which exists in three subtypes: cBAF, PBAF and GBAF/ncBAF. We used comprehensive biochemical analysis to characterize the interactions between FET oncoproteins, SWI/SNF complexes and the transcriptional coactivator BRD4. Here, we report that FET oncoproteins bind all three main SWI/SNF subtypes cBAF, PBAF and GBAF, and that FET oncoproteins interact indirectly with BRD4 via their shared interaction partner SWI/SNF. Furthermore, chromatin immunoprecipitation sequencing and proteomic analysis showed that FET oncoproteins, SWI/SNF components and BRD4 co-localize on chromatin and interact with mediator and RNA Polymerase II. Our results provide a possible molecular mechanism for the FET-fusion-induced oncogenic transcriptional profiles and may lead to novel therapies targeting aberrant SWI/SNF complexes and/or BRD4 in FET-fusion-caused malignancies.

摘要

含有 FET（FUS、EWSR1、TAF15）家族蛋白之一的 FET 融合癌蛋白与其他转录因子伴侣并列，是 20 多种肉瘤和白血病的特征。FET 癌蛋白与 SWI/SNF 染色质重塑复合物结合，该复合物存在三种亚型：cBAF、PBAF 和 GBAF/ncBAF。我们使用全面的生化分析来表征 FET 癌蛋白、SWI/SNF 复合物和转录共激活因子 BRD4 之间的相互作用。在这里，我们报告 FET 癌蛋白结合三种主要的 SWI/SNF 亚型 cBAF、PBAF 和 GBAF，并且 FET 癌蛋白通过其共享的相互作用伙伴 SWI/SNF 与 BRD4 间接相互作用。此外，染色质免疫沉淀测序和蛋白质组学分析表明，FET 癌蛋白、SWI/SNF 成分和 BRD4 共定位于染色质上，并与中介体和 RNA 聚合酶 II 相互作用。我们的结果为 FET 融合诱导的致癌转录谱提供了一个可能的分子机制，并可能导致针对 FET 融合引起的恶性肿瘤中异常 SWI/SNF 复合物和/或 BRD4 的新疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/e0ce936227ba/MOL2-16-2470-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/9c7c73d28c8c/MOL2-16-2470-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/7a1e8c5306ab/MOL2-16-2470-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/5dbe1f3c225d/MOL2-16-2470-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/2442774d8f3d/MOL2-16-2470-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/da29ed17c74c/MOL2-16-2470-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/e0ce936227ba/MOL2-16-2470-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/9c7c73d28c8c/MOL2-16-2470-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/7a1e8c5306ab/MOL2-16-2470-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/5dbe1f3c225d/MOL2-16-2470-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/2442774d8f3d/MOL2-16-2470-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/da29ed17c74c/MOL2-16-2470-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada8/9251840/e0ce936227ba/MOL2-16-2470-g006.jpg

相似文献

[1]
FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.

Mol Oncol. 2022-7

[2]
FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

EMBO Rep. 2019-4-8

[3]
Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

J Biol Chem. 2018-1-26

[4]
FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.

Protein Sci. 2021-7

[5]
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.

Nat Cell Biol. 2018-11-5

[6]
The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer.

Cancer Treat Res. 2023

[7]
Advances in the role of SWI/SNF complexes in tumours.

J Cell Mol Med. 2023-4

[8]
Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.

J Virol. 2019-7-30

[9]
Collaboration between distinct SWI/SNF chromatin remodeling complexes directs enhancer selection and activation of macrophage inflammatory genes.

Immunity. 2024-8-13

[10]
SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.

PLoS One. 2012-3-19

引用本文的文献

[1]
SWI/SNF-type complexes-transcription factor interplay: a key regulatory interaction.

Cell Mol Biol Lett. 2025-3-10

[2]
Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets.

MedComm (2020). 2024-10-15

[3]
Cbx4 SUMOylates BRD4 to regulate the expression of inflammatory cytokines in post-traumatic osteoarthritis.

Exp Mol Med. 2024-10

[4]
Hijacking the BAF complex: the mechanistic interplay of ARID1A and EWS::FLI1 in Ewing sarcoma.

Mol Oncol. 2025-4

[5]
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges.

Front Cell Dev Biol. 2024-6-14

[6]
Sequence variations of phase-separating proteins and resources for studying biomolecular condensates.

Acta Biochim Biophys Sin (Shanghai). 2023-7-18

[7]
TATA-box-binding protein-associated factor 15 is a novel biomarker that promotes cell proliferation and migration in gastrointestinal stromal tumor.

World J Gastroenterol. 2023-5-21

[8]
TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway.

Sci Rep. 2023-4-10

[9]
Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications.

Cancers (Basel). 2023-1-6

[10]
TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities.

Trends Cancer. 2022-12

本文引用的文献

[1]
The oncogenic transcription factor FUS-CHOP can undergo nuclear liquid-liquid phase separation.

J Cell Sci. 2021-9-1

[2]
FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.

Protein Sci. 2021-7

[3]
Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription.

Nat Commun. 2021-3-5

[4]
Partitioning of cancer therapeutics in nuclear condensates.

Science. 2020-6-19

[5]
Opposing Functions of BRD4 Isoforms in Breast Cancer.

Mol Cell. 2020-5-23

[6]
Roles of the BRD4 short isoform in phase separation and active gene transcription.

Nat Struct Mol Biol. 2020-3-16

[7]
The neXtProt knowledgebase in 2020: data, tools and usability improvements.

Nucleic Acids Res. 2020-1-8

[8]
EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.

Nucleic Acids Res. 2019-10-10

[9]
The FUS-DDIT3 Interactome in Myxoid Liposarcoma.

Neoplasia. 2019-6-17

[10]
BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.

Nat Commun. 2019-4-23

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索